NEW YORK (
) hit a new 52-week high Monday as it is currently trading at $119.58, above its previous 52-week high of $119.41 with 50,811 shares traded as of 9:35 a.m. ET. Average volume has been 1.4 million shares over the past 30 days.
Regeneron has a market cap of $7.18 billion and is part of the
industry. Shares are up 115% year to date as of the close of trading on Friday.
Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines for the treatment of serious medical conditions in the United States.
- Sign up for TheStreet's FREE Dividend and Income Investor Newsletter
TheStreet Ratings rates Regeneron as a
. The company's strengths can be seen in multiple areas, such as its solid stock price performance and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and weak operating cash flow. You can view the full
52-week high stocks
or get investment ideas from our